The value of oligoclonal bands in the multiple sclerosis diagnostic criteriaGeorgina Arrambide, Xavier Montalbán, Mar Tintoré et al.|Brain|2018Cited by 158
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Manuel Comabella, Eduard Sarró et al.|Brain|2020Cited by 136
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Mar Tintoré, Carmen Espejo et al.|Neurology|2016Cited by 108
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosisLaura Calvo‐Barreiro, Carmen Espejo, Herena Eixarch et al.|Autoimmunity Reviews|2017Cited by 95
Immunosenescence in multiple sclerosis: the identification of new therapeutic targetsMaría Dema, Carmen Espejo, Herena Eixarch et al.|Autoimmunity Reviews|2021Cited by 94